Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Predictive Values of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults.

Lu J, He J, Li M, Tang X, Hu R, Shi L, Su Q, Peng K, Xu M, Xu Y, Chen Y, Yu X, Yan L, Wang T, Zhao Z, Qin G, Wan Q, Chen G, Dai M, Zhang D, Gao Z, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Du R, Cheng D, Liu C, Wang Y, Wu S, Yang T, Deng H, Li D, Lai S, Bloomgarden ZT, Chen L, Zhao J, Mu Y, Ning G, Wang W, Bi Y; 4C Study Group.

Diabetes Care. 2019 May 31. pii: dc181390. doi: 10.2337/dc18-1390. [Epub ahead of print]

PMID:
31152120
2.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2019 Jan;25(1):69-100. doi: 10.4158/CS-2018-0535. Erratum in: Endocr Pract. 2019 Feb;25(2):204.

PMID:
30742570
3.

Discordance between HbA1c and glycemia.

Misra A, Bloomgarden ZT.

J Diabetes. 2018 Dec;10(12):908-910. doi: 10.1111/1753-0407.12843. Epub 2018 Sep 30. No abstract available.

PMID:
30126041
4.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.

Grunberger G, Handelsman Y, Bloomgarden ZT, Fonseca VA, Garber AJ, Haas RA, Roberts VL, Umpierrez GE.

Endocr Pract. 2018 Mar;24(3):302-308. doi: 10.4158/PS-2017-0155.

PMID:
29547046
5.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17.

PMID:
29368965
6.

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

Fonseca VA, Bloomgarden ZT, Dagogo-Jack S, Grunberger G, Einhorn D, Garber AJ, Handelsman Y, Hirsch IB, Umpierrez GE.

Endocr Pract. 2017 Nov;23(11):1345-1349. doi: 10.4158/EP-2017-0052.

PMID:
29190135
7.

American Society of Clinical Oncology Summit on Addressing Obesity Through Multidisciplinary Provider Collaboration: Key Findings and Recommendations for Action.

Ligibel JA, Alfano CM, Hershman DL, Merrill JK, Basen-Engquist K, Bloomgarden ZT, Demark-Wahnefried W, Dixon S, Hassink SG, Jakicic JM, Morton JM, Okwuosa TM, Powell-Wiley TM, Rothberg AE, Stephens M, Streett SE, Wild RA, Westman EA, Williams RJ, Wollins DS, Hudis CA.

Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S34-S39. doi: 10.1002/oby.21987.

8.

Response to Comment on Bloomgarden et al. Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old? Diabetes Care 2017;40:526-528.

Bloomgarden ZT, Einhorn D, Handelsman Y.

Diabetes Care. 2017 Oct;40(10):e154. doi: 10.2337/dci17-0027. No abstract available.

PMID:
28931711
9.

Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.

Bloomgarden ZT, Kosiborod MN, Handelsman Y.

J Am Coll Cardiol. 2017 Sep 12;70(11):1336-1338. doi: 10.1016/j.jacc.2017.07.773. No abstract available.

10.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M.

Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.

PMID:
28437620
11.

Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old?

Bloomgarden ZT, Einhorn D, Handelsman Y.

Diabetes Care. 2017 Apr;40(4):526-528. doi: 10.2337/dci16-0043. No abstract available.

PMID:
28325800
12.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.

Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M, Zangeneh F, Bush MA.

Endocr Pract. 2017 Apr 2;23(4):479-497. doi: 10.4158/EP171764.GL. Epub 2017 Feb 3.

PMID:
28156151
13.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2017 Feb;23(2):207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17.

PMID:
28095040
14.

Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add-ons to metformin: A retrospective cohort database study.

Bloomgarden ZT, Tunceli K, Liu J, Brodovicz KG, Mavros P, Engel SS, Radican L, Chen Y, Rajpathak S, Qiu Y, Brudi P, Fonseca V.

J Diabetes. 2017 Jul;9(7):677-688. doi: 10.1111/1753-0407.12461. Epub 2016 Oct 7.

PMID:
27531167
15.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.

Handelsman Y, Henry RR, Bloomgarden ZT, Dagogo-Jack S, DeFronzo RA, Einhorn D, Ferrannini E, Fonseca VA, Garber AJ, Grunberger G, LeRoith D, Umpierrez GE, Weir MR.

Endocr Pract. 2016 Jun;22(6):753-62. doi: 10.4158/EP161292.PS. Epub 2016 Jun 1.

PMID:
27082665
16.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Henry RR, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE).

Endocr Pract. 2016 Jan;22(1):84-113. doi: 10.4158/EP151126.CS. No abstract available.

PMID:
26731084
17.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE).

Endocr Pract. 2015 Dec;21(12):1403-14. doi: 10.4158/EP151063.CS.

PMID:
26642101
18.

Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis.

Bloomgarden ZT.

J Diabetes. 2016 Mar;8(2):175-6. doi: 10.1111/1753-0407.12353. Epub 2015 Dec 29. No abstract available.

PMID:
26611882
19.

SGLT-2 INHIBITION ADDED TO GLP-1 AGONIST THERAPY FOR TYPE 2 DIABETES: WHAT IS THE BENEFIT?

Bloomgarden ZT, Handelsman Y.

Endocr Pract. 2015 Dec;21(12):1442-4. doi: 10.4158/EP151013.CO. Epub 2015 Oct 20. No abstract available.

PMID:
26484408
20.

Approaches to treatment 2: Comparison of American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA) type 2 diabetes treatment guidelines.

Bloomgarden ZT, Handelsman Y.

J Diabetes. 2016 Jan;8(1):4-6. doi: 10.1111/1753-0407.12345. Epub 2015 Dec 1. No abstract available. Erratum in: J Diabetes. 2017 Apr;9(4):423.

PMID:
26431291
21.

Approaches to treatment 1: How is type 2 diabetes actually treated?

Bloomgarden ZT.

J Diabetes. 2015 Nov;7(6):747-8. doi: 10.1111/1753-0407.12329. No abstract available.

PMID:
26211568
22.

Sleep duration and snoring associate with hypertension and glycaemic control in patients with diabetes.

Wang T, Lu J, Wang W, Mu Y, Zhao J, Liu C, Chen L, Shi L, Li Q, Yang T, Yan L, Wan Q, Wu S, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Xu M, Sun J, Bi Y, Lai S, Bloomgarden ZT, Li D, Ning G.

Diabet Med. 2015 Aug;32(8):1001-7. doi: 10.1111/dme.12809. Epub 2015 Jun 12.

PMID:
25996982
23.

AACE/ACE comprehensive diabetes management algorithm 2015.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH.

Endocr Pract. 2015 Apr;21(4):438-47. doi: 10.4158/EP15693.CS. Epub 2015 Apr 15. No abstract available.

PMID:
25877012
24.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovič L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F.

Endocr Pract. 2015 Apr;21 Suppl 1:1-87. doi: 10.4158/EP15672.GL. No abstract available.

25.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.

Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovič L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F.

Endocr Pract. 2015 Apr;21(4):413-37. No abstract available.

PMID:
27408942
26.

New approaches to wound healing for diabetes.

Bloomgarden ZT, Drexler A, Farley S.

J Diabetes. 2015 Jul;7(4):435-6. doi: 10.1111/1753-0407.12295. Epub 2015 May 6. No abstract available.

PMID:
25817830
27.

The future of diabetes.

Bloomgarden ZT.

Can J Diabetes. 2015 Jun;39(3):204-5. doi: 10.1016/j.jcjd.2015.02.001. Epub 2015 Mar 26. No abstract available.

PMID:
25817567
28.

Advances in sleep research.

Einhorn D, Bloomgarden ZT.

J Diabetes. 2015 Jan;7(1):8-9. doi: 10.1111/1753-0407.12211. No abstract available.

PMID:
25244666
29.

Individualizing therapy: do we have the tools to do it?

Shaw JE, Bloomgarden ZT.

J Diabetes. 2015 Jan;7(1):1-2. doi: 10.1111/1753-0407.12218. Epub 2014 Oct 20. No abstract available.

PMID:
25209957
30.

Afrezza: some questions about a new approach to prandial insulin.

Bloomgarden ZT.

J Diabetes. 2014 Nov;6(6):489-90. doi: 10.1111/1753-0407.12217. Epub 2014 Oct 20. No abstract available.

PMID:
25209874
31.

Is glycemic control a quinidine-like intervention?

Bloomgarden ZT.

J Diabetes. 2014 Sep;6(5):387-8. doi: 10.1111/1753-0407.12170. Epub 2014 Jul 16. No abstract available.

PMID:
24842383
32.

Basal insulin or longacting GLP-1 receptor agonists-making the right choice.

Bloomgarden ZT.

Lancet Diabetes Endocrinol. 2014 Jun;2(6):439-41. doi: 10.1016/S2213-8587(14)70036-1. Epub 2014 Apr 4. No abstract available.

PMID:
24731676
33.

Metformin associated with better cardiovascular outcomes than other glycaemic therapies.

Bloomgarden ZT.

Evid Based Med. 2014 Jun;19(3):103. doi: 10.1136/eb-2013-101682. Epub 2014 Jan 6. No abstract available.

PMID:
24393715
34.

Association is not causation, particularly with "adjustment".

Bloomgarden ZT.

J Diabetes. 2014 May;6(3):195-6. doi: 10.1111/1753-0407.12123. Epub 2014 Feb 18. No abstract available.

PMID:
24393544
35.
36.

Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study.

Bi Y, Lu J, Wang W, Mu Y, Zhao J, Liu C, Chen L, Shi L, Li Q, Wan Q, Wu S, Yang T, Yan L, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Zhang J, Sun J, Dai M, Xu M, Xu Y, Chen Y, Lai S, Bloomgarden ZT, Li D, Ning G.

J Diabetes. 2014 Mar;6(2):147-57. doi: 10.1111/1753-0407.12108. Epub 2014 Jan 9.

PMID:
24237858
37.

Diabetes and cancer--an AACE/ACE consensus statement.

Handelsman Y, Leroith D, Bloomgarden ZT, Dagogo-Jack S, Einhorn D, Garber AJ, Grunberger G, Harrell RM, Gagel RF, Lebovitz HE, McGill JB, Hennekens CH.

Endocr Pract. 2013 Jul-Aug;19(4):675-93. doi: 10.4158/EP13248.CS. No abstract available. Erratum in: Endocr Pract. 2013 Sep-Oct;19(5):899.

PMID:
23978590
38.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, Davidson MH.

Endocr Pract. 2013 May-Jun;19(3):536-57. doi: 10.4158/EP13176.CS. No abstract available.

39.

AACE comprehensive diabetes management algorithm 2013.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH; American Association of Clinical Endocrinologists.

Endocr Pract. 2013 Mar-Apr;19(2):327-36. No abstract available.

PMID:
23598536
40.

The Journal of diabetes: continuing the dialogue.

Bloomgarden ZT, Drexler A, Einhorn D, Grunberger G, Guan Y, Handelsman Y, Hu JC, Li X, Liu J, Wang W, Weng J, Ning G.

J Diabetes. 2013 Jun;5(2):95-6. doi: 10.1111/1753-0407.12045. No abstract available.

PMID:
23489930
41.

The clinical approach to the detection of lipodystrophy - an AACE consensus statement.

Handelsman Y, Oral EA, Bloomgarden ZT, Brown RJ, Chan JL, Einhorn D, Garber AJ, Garg A, Garvey WT, Grunberger G, Henry RR, Lavin N, Tapiador CD, Weyer C; American Association of Clinical Endocrinologists.

Endocr Pract. 2013 Jan-Feb;19(1):107-16. No abstract available.

42.

The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations.

Garber AJ, Blonde L, Bloomgarden ZT, Handelsman Y, Dagogo-Jack S.

Endocr Pract. 2013 Jan-Feb;19(1):100-6. doi: 10.4158/EP12325.OR. Review.

PMID:
23337160
43.

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.

Bloomgarden ZT, Blonde L, Garber AJ, Wysham CH.

Endocr Pract. 2012 Nov-Dec;18 Suppl 3:6-26; quiz 27-8. doi: 10.4158/EP12300.RA. Review.

PMID:
23315305
44.

Diabetes: East meets West. The Joint American Association of Clinical Endocrinologists-Chinese Society of Endocrinology (AACE-CSE) Symposium.

Bloomgarden ZT.

J Diabetes. 2012 Sep;4(3):221-6. doi: 10.1111/j.1753-0407.2012.00228.x. No abstract available.

PMID:
22898104
45.

How do we gauge the success of treatment of diabetes?

Zimmet P, Bloomgarden ZT.

J Diabetes. 2012 Sep;4(3):193-4. doi: 10.1111/j.1753-0407.2012.00218.x. No abstract available.

PMID:
22727202
46.

Learning from ORIGIN.

Bloomgarden ZT.

J Diabetes. 2012 Sep;4(3):191-2. doi: 10.1111/j.1753-0407.2012.00215.x. No abstract available.

PMID:
22716648
47.

Hypoglycemia in type 2 diabetes: current controversies and changing practices.

Bloomgarden ZT, Einhorn D.

Front Endocrinol (Lausanne). 2012 May 21;3:66. doi: 10.3389/fendo.2012.00066. eCollection 2012.

48.

Is there a U-shaped curve of A1c versus mortality?

Bloomgarden ZT, Drexler A.

J Diabetes. 2012 Jun;4(2):107-8. doi: 10.1111/j.1753-0407.2012.00199.x. No abstract available.

PMID:
22443259
49.

Diabetes: the prototypical non-communicable disease.

Bloomgarden ZT, Ning G.

J Diabetes. 2012 Jun;4(2):110-2. doi: 10.1111/j.1753-0407.2012.00185.x. No abstract available.

PMID:
22243761
50.

Final "perspectives on the news": American Association of Clinical Endocrinology and American Diabetes Association 2011.

Bloomgarden ZT.

Diabetes Care. 2011 Dec;34(12):e176-81. doi: 10.2337/dc11-1800. No abstract available.

Supplemental Content

Loading ...
Support Center